Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Eremenko T et al. | 1997 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
Schimmelpfeng J et al. | 1997 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) and HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
Reipert BM et al. | 1996 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2–65 µT |
Mevissen M et al. | 1996 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, co-exposure | 50 µT |
Dees C et al. | 1996 | intact cell/cell culture, MCF-7 and T-47D cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz, co-exposure | 1.2–900 µT |
Miyakoshi J et al. | 1996 | intact cell/cell culture, CHO (Chinese hamster ovary) cells | magnetic field, 50/60 Hz | 5 mT |
Cridland NA et al. | 1996 | intact cell/cell culture, HF-19 cells (normal human fibroblasts derived from fetal female lung) | magnetic field, 50/60 Hz, power transmission line | 20 µT–20 mT |
Raskmark P et al. | 1996 | intact cell/cell culture, transformed human epithelial amnion cells (AMA) | magnetic field, 50/60 Hz | 20–50 µT |
West RW et al. | 1996 | intact cell/cell culture, JB6 Cl 41 cells (BALB/c mouse normal epithelial cell line) | magnetic field, 50/60 Hz | 1–100 µT |
Kula B et al. | 1996 | intact cell/cell culture, fibroblasts | magnetic field, static magnetic field, low frequency, 50/60 Hz | 20–490 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.